Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secoya Technologies is a Belgian pharmaceutical manufacturing technology company and Université Libre de Bruxelles spin-off focused on particle engineering, process intensification, and microfluidic equipment for (bio)pharmaceutical production. Rather than developing its own therapeutics, the company provides equipment, process development, and scale-up solutions spanning crystallization, emulsification, pervaporation, and chemical synthesis. Its product portfolio includes crystallization systems such as SCT-LAB 2.0, SCT-PILOT, and SCT-ICE, as well as encapsulation and droplet-generation tools including InstaDrop and RayDrop. Secoya positions its platform around quality-by-design, continuous manufacturing, and precise control of particle size, droplet formation, and process conditions to help pharma and biotech clients accelerate development and commercialization. The business appears to be commercial-stage, generating revenue from instrument sales, services, and client projects rather than from a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Secoya Technologies.